Profile for European Patent Office Patent: 1551372
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for European Patent Office Patent: 1551372
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
⤷ Sign Up | Dec 12, 2027 | Alpharma Pharms | EMBEDA | morphine sulfate; naltrexone hydrochloride |
⤷ Sign Up | Dec 12, 2027 | Pfizer | TROXYCA ER | naltrexone hydrochloride; oxycodone hydrochloride |
⤷ Sign Up | Jul 3, 2025 | Alpharma Pharms | EMBEDA | morphine sulfate; naltrexone hydrochloride |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |